Option chain shows key data for Nexalin Technology's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Nexalin Technology.

Nexalin Technology (NASDAQ:NXL) Stock, Option Chain

Nexalin Technology

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Wall Street

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

CERO

EFSH

FOXO

HOVR

MNDY

RAPT

Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results

Biotech

Health Care

Exclusives

General

NXLIW

Nexalin says the study published in the Journal of Alzheimer&#39;s Disease shows DIFS may enhance cognition in mild Alzheimer&#39;s patients.

EXCLUSIVE: Nexalin Technology Says New Data Confirms Investigational Non-Invasive Neurostimulation Device Improves Cognitive Function, Restores Brain Activity in Alzheimer&#39;s Patients (UPDATED)

Market-Moving Exclusives

Nexalin Technology&#39;s clinical trial results highlight notable cognitive improvements in Alzheimer&#39;s patients using Deep Intracranial Frequency Stimulation technology. The study showed significant memory and cognition gains, increased hippocampal activity, and minimal side effects.

EXCLUSIVE: Nano-Cap Nexalin&#39;s Drug-Free Alternative For Alzheimer&#39;s Shows Improved Memory, Cognitive Function In Small Study

Nexalin Technology Inc

NEXLIVING CMNTYS INC by NEXLIVING CMNTYS INC.

Nuix Ltd

Press Releases

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

Nexalin Technology Receives IRB Approval in Brazil and  Begins Clinical Trial for Anxiety and Insomnia

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

Financing

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Biomerica

BioSig Technologies

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Daxor

electroCore

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

INVO Fertility

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

PAVmed

Predictive Oncology

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Beyond Air

Xylo Technologies Ltd. - American Depositary Shares

Comments

Nexalin Technology

Nexalin Technology (NXL) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell